Who should not take Liraglutide (Saxenda / Victoza)?
Documented caution flags for Liraglutide (Saxenda / Victoza) include mTC / MEN-2 history (boxed warning) and pancreatitis history. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for Liraglutide (Saxenda / Victoza) is limited.
Documented caution flags for Liraglutide (Saxenda / Victoza)
- MTC / MEN-2 history (boxed warning)
- Pancreatitis history
- Pregnancy / nursing
- Severe hypersensitivity
Reported side effects to weigh
- Nausea (often more pronounced than weekly Semaglutide)
- Constipation or diarrhea
- Injection-site reaction
- Pancreatitis (warning, not boxed)
References
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management (SCALE Obesity) — Pi-Sunyer X et al., NEJM, 2015
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (LEADER) — Marso SP et al., New England Journal of Medicine, 2016
- Victoza (liraglutide) — Drugs@FDA approval record (ApplNo 022341) — FDA, Drugs@FDA
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on Liraglutide (Saxenda / Victoza)
Full Liraglutide (Saxenda / Victoza) breakdownLiraglutide (Saxenda / Victoza) what it's used forLiraglutide (Saxenda / Victoza) side effectsLiraglutide (Saxenda / Victoza) how to take itLiraglutide (Saxenda / Victoza) mistakes to avoidLiraglutide (Saxenda / Victoza) half-lifeLiraglutide (Saxenda / Victoza) how long to workLiraglutide (Saxenda / Victoza) legal statusLiraglutide (Saxenda / Victoza) how it worksAsk the AI Coach
Last updated 2026-06-15.